Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexible, Intensive vs. Conventional Insulin Therapy in Type 2 Diabetes
NCT00440284Phase 3Unknown
- Sponsor
- Friedrich Schiller University Jena
- Start
- Jan 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Friedrich Schiller University Jena. Primary endpoint: Glycosylated Hemoglobin at 17 weeks. Status: unknown.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00440284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440284.